Abstract
Drug dependence is understood as a complex disorder associated with biological, emotional, and social factors. Consequently, an individual might develop dependence as a result of the interaction of those factors or even one of them alone, which favors the repetitive use that leads to dependence.
The original version of this chapter was revised: Name of two authors were excluded from Chapter 2. The erratum to this chapter is available at 10.1007/978-3-319-43172-7_15
An erratum to this chapter can be found at http://dx.doi.org/10.1007/978-3-319-43172-7_15
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC.
Ashton, H. (2005). The diagnosis and management of benzodiazepine dependence. Current Opinion in Psychiatry, 18(3), 249–255. doi:10.1097/01.yco.0000165594.60434.84.
Azevedo, F. A., Carvalho, L. R., Grinberg, L. T., Farfel, J. M., Ferretti, R. E., Leite, R. E., et al. (2009). Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. Journal of Comparative Neurology, 513(5), 532–541. doi:10.1002/cne.21974.
Bechara, A. (2005). Decision making, impulse control and loss of willpower to resist drugs: A neurocognitive perspective. Nature Neuroscience, 8(11), 1458–1463. doi:10.1038/nn1584.
Blackburn, J. R., Phillips, A. G., Jakubovic, A., & Fibiger, H. C. (1989). Dopamine and preparatory behavior: II. A neurochemical analysis. Behavioral Neuroscience, 103(1), 15–23.
Carlini, E. A., Galduróz, J. C., Noto, A. R., Carlini, C. M., Oliveira, L. G., & Nappo, S. A. (2007). II Levantamento domiciliar sobre o uso de drogas psicotrópicas no Brasil: Estudo envolvendo as 108 maiores cidades do país—2005. São Paulo: Páginas & Letras.
Cone, E. J. (1995). Pharmacokinetics and pharmacodynamics of cocaine. Journal of Analytical Toxicology, 19(6), 459–478.
Di Chiara, G. (2002). Nucleus accumbens shell and core dopamine: Differential role in behavior and addiction. Behavioural Brain Research, 137(1–2), 75–114.
Di Chiara, G., & Bassareo, V. (2007). Reward system and addiction: What dopamine does and doesn’t do. Current Opinion in Pharmacology, 7(1), 69–76. doi:10.1016/j.coph.2006.11.003.
Di Chiara, G., Tanda, G., Bassareo, V., Pontieri, F., Acquas, E., Fenu, S., et al. (1999). Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine. Annals of the New York Academy of Sciences, 877, 461–485.
Fattore, L., Fadda, P., Spano, M. S., Pistis, M., & Fratta, W. (2008). Neurobiological mechanisms of cannabinoid addiction. Molecular and Cellular Endocrinology, 286(1–2 Suppl 1), S97–S107. doi:10.1016/j.mce.2008.02.006.
Fibiger, H.C. (1993). Mesolimbic dopamine: An analysis of its role in motivated behavior. Paper presentd at the Seminars in Neuroscience.
Gianoulakis, C. (1996). Implications of endogenous opioids and dopamine in alcoholism: Human and basic science studies. Alcohol and Alcoholism, 31(Suppl 1), 33–42.
Gilpin, N. W., & Koob, G. F. (2008). Neurobiology of alcohol dependence: Focus on motivational mechanisms. Alcohol Research and Health, 31(3), 185–195.
Glickman, S. E., & Schiff, B. B. (1967). A biological theory of reinforcement. Psychological Review, 74(2), 81–109.
Goldstein, R. Z., & Volkow, N. D. (2002). Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex. The American Journal of Psychiatry, 159(10), 1642–1652.
Gong, J. P., Onaivi, E. S., Ishiguro, H., Liu, Q. R., Tagliaferro, P. A., Brusco, A., et al. (2006). Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain. Brain Research, 1071(1), 10–23. doi:10.1016/j.brainres.2005.11.035.
Herz, A. (1997). Endogenous opioid systems and alcohol addiction. Psychopharmacology (Berlin), 129(2), 99–111.
Kalivas, P. W. (2007). Neurobiology of cocaine addiction: Implications for new pharmacotherapy. American Journal on Addictions, 16(2), 71–78. doi:10.1080/10550490601184142.
Koob, G. F. (1992). Drugs of abuse: Anatomy, pharmacology and function of reward pathways. Trends in Pharmacological Sciences, 13(5), 177–184.
Koob, G. F., & Bloom, F. E. (1988). Cellular and molecular mechanisms of drug dependence. Science, 242(4879), 715–723.
Koob, G. F., Buck, C. L., Cohen, A., Edwards, S., Park, P. E., Schlosburg, J. E., et al. (2014). Addiction as a stress surfeit disorder. Neuropharmacology, 76, 370–382. doi:10.1016/j.neuropharm.2013.05.024.
Koob, G. F., & Le Moal, M. (1997). Drug abuse: Hedonic homeostatic dysregulation. Science, 278(5335), 52–58.
Koob, G. F., & Le Moal, M. (2005a). Neurobiology of addiction. Cambridge: Academic Press.
Koob, G. F., & Le Moal, M. (2005b). Plasticity of reward neurocircuitry and the ‘dark side’ of drug addiction. Nature Neuroscience, 8(11), 1442–1444. doi:10.1038/nn1105-1442.
Koob, G. F., & Le Moal, M. (2008). Addiction and the brain antireward system. Annual Review of Psychology, 59, 29–53. doi:10.1146/annurev.psych.59.103006.093548.
Koob, G. F., & Volkow, N. D. (2010). Neurocircuitry of addiction. Neuropsychopharmacology, 35(1), 217–238. doi:10.1038/npp.2009.110.
Kreek, M. J., & Koob, G. F. (1998). Drug dependence: Stress and dysregulation of brain reward pathways. Drug and Alcohol Dependence, 51(1–2), 23–47.
Maldonado, R., Valverde, O., & Berrendero, F. (2006). Involvement of the endocannabinoid system in drug addiction. Trends in Neurosciences, 29(4), 225–232. doi:10.1016/j.tins.2006.01.008.
Milner, P. M. (1991). Brain-stimulation reward: A review. Canadian Journal of Psychology, 45(1), 1–36.
Nestler, E. J. (2005). The neurobiology of cocaine addiction. Science and Practice Perspectives, 3(1), 4–10.
Noël, X., Van Der Linden, M., & Bechara, A. (2006). The neurocognitive mechanisms of decision-making, impulse control, and loss of willpower to resist drugs. Psychiatry (Edgmont), 3(5), 30–41.
Olds, J., & Milner, P. (1954). Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. Journal of Comparative and Physiological Psychology, 47(6), 419–427.
Owen, R. T., & Tyrer, P. (1983). Benzodiazepine dependence: A review of the evidence. Drugs, 25(4), 385–398.
Petursson, H., & Lader, M. H. (1981). Benzodiazepine dependence. British Journal of Addiction, 76(2), 133–145.
Piazza, P. V., & Le Moal, M. (1998). The role of stress in drug self-administration. Trends in Pharmacological Sciences, 19(2), 67–74.
Piazza, P. V., & Le Moal, M. L. (1996). Pathophysiological basis of vulnerability to drug abuse: Role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annual Review of Pharmacology and Toxicology, 36, 359–378. doi:10.1146/annurev.pa.36.040196.002043.
Robinson, J. B. (1985). Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, N-methylamphetamine and deprenyl. Biochemical Pharmacology, 34(23), 4105–4108.
Samson, H. H., & Harris, R. A. (1992). Neurobiology of alcohol abuse. Trends in Pharmacological Sciences, 13(5), 206–211.
Seamans, J. K., & Yang, C. R. (2004). The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Progress in Neurobiology, 74(1), 1–58. doi:10.1016/j.pneurobio.2004.05.006.
Stahl, S.M. (2010). Psicofarmacologia: Base neurocientífica e aplicações práticas (3 ed.). Guanabara Koogan.
Tabakoff, B., & Hoffman, P. L. (2013). The neurobiology of alcohol consumption and alcoholism: An integrative history. Pharmacology, Biochemistry and Behavior, 113, 20–37. doi:10.1016/j.pbb.2013.10.009.
Volkow, N. D., & Fowler, J. S. (2000). Addiction, a disease of compulsion and drive: Involvement of the orbitofrontal cortex. Cerebral Cortex, 10(3), 318–325.
Wang, J., & Ueda, N. (2008). Role of the endocannabinoid system in metabolic control. Current Opinion in Nephrology and Hypertension, 17(1), 1–10. doi:10.1097/MNH.0b013e3282f29071.
Weiss, F., Maldonado-Vlaar, C. S., Parsons, L. H., Kerr, T. M., Smith, D. L., & Ben-Shahar, O. (2000). Control of cocaine-seeking behavior by drug-associated stimuli in rats: Effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens. Proceedings of the National Academy of Sciences of the United States of America, 97(8), 4321–4326.
Wise, R. A. (1980). Action of drugs of abuse on brain reward systems. Pharmacology, Biochemistry and Behavior, 13(Suppl 1), 213–223.
Wise, R. A. (1996). Addictive drugs and brain stimulation reward. Annual Review of Neuroscience, 19, 319–340. doi:10.1146/annurev.ne.19.030196.001535.
Wise, R. A. (2002). Brain reward circuitry: Insights from unsensed incentives. Neuron, 36(2), 229–240.
Wise, R. A., & Bozarth, M. A. (1987). A psychomotor stimulant theory of addiction. Psychological Review, 94(4), 469–492.
World Health Organization. (2004). Neuroscience of psychoactive substance use and dependence. Geneva: World Health Organization.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bedendo, A., Andrade, A.L.M., Noto, A.R. (2016). Neurobiology of Substance Abuse. In: Andrade, A., De Micheli, D. (eds) Innovations in the Treatment of Substance Addiction. Springer, Cham. https://doi.org/10.1007/978-3-319-43172-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-43172-7_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43170-3
Online ISBN: 978-3-319-43172-7
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)